CPHD

基本解釋

Conclusion: The application of Lig was definite efficacy in the patients with CPHD.
結論：川芎嗪在改善肺心病患者血液流變學及臨床療效上作用肯定。
Objective:To explore the application of PQS in clinics and improve immunological responses of CPHD patients.
目的:為了開發(fā)西洋參在臨床醫(yī)學方面的應用,提高CPHD病人的各項免疫指標。
These levels of blood L,P and L/P ratio significantly increa-sed(in all P 呼酸合并代酸組的血 L、P 含量和 L/P 比值顯著增加;與呼酸組比較差異顯著(P 值均
Methods:Fifty CPHD patients were monitored in persistent oxygen uptake and non-oxygen uptake for 24 hours by MV5 and MV1 bipolar leading of MIKE 8500 tape-recorder.
方法 :對 5 0例肺心病患者應用美國麥克 85 0 0 T系統(tǒng)磁帶式記錄儀 ,MV5和 MV1雙極導聯連續(xù)同步監(jiān)測 2 4小時 ,并分別在 2 4小時持續(xù)低流量吸氧及非吸氧下監(jiān)測。
Objective: To discuss the efficiency of Ligustrazine (Lig) in blood rheology and clinical maniifestation in the treatment of chronic pulmonary heart disease (CPHD).
摘要目的：探討川芎嗪對改善慢性肺源性心臟病（肺心?。┗颊哐毫髯儗W及臨床療效的作用。